Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 4 Grant or award Director acquired 1,743 shares (grant or award)
  9. 4 Grant or award Director acquired 3,166 shares (grant or award)
  10. 4 Grant or award Director acquired 1,073 shares (grant or award)
  11. 4 Grant or award Director acquired 1,835 shares (grant or award)
  12. 4 Grant or award Director acquired 2,418 shares (grant or award)
  13. 4 Grant or award Director acquired 4,391 shares (grant or award)
  14. 4 Grant or award Director acquired 1,489 shares (grant or award)
  15. 4 Grant or award Director acquired 2,545 shares (grant or award)
  16. 4 Insider Changes in Ownership
  17. 4 Grant or award Chief Financial Officer acquired 1,180 shares (grant or award)
  18. 4 Grant or award President & CEO acquired 413 shares (grant or award)
  19. 4 Grant or award Director acquired 1,642 shares (grant or award)
  20. 4 Grant or award Director acquired 2,905 shares (grant or award)

Page 12 of 37 · 739 filings